Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology.
Get in touch with the Sixfold team: Sixfold Bioscience; George Foot; Anna PerdrixInterested in joining the team? Check out open roles hereIn this episode, we cover: Sixfold Bioscience and challenges with RNA delivery How George and Anna started SixfoldSwitching between an academia and entrepreneurship mindsetBuilding a biotech totally from scratchTwitter debate—founder led bio vs venture incubation Building a diverse (majority women!) team and tips for recruitmentSixfold's big visionBroader trends to be excited about in biotech and deep tech